MedPath

study of water soluble extract of Shalaparni and Bhringaraja for the treatment of Essential Hypertension â??

Phase 2
Conditions
Health Condition 1: null- Diagnosed stage-2 Essential Hypertension having no known complications of disease
Registration Number
CTRI/2017/12/010843
Lead Sponsor
ational institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

i.Patients willing to sign the consent form for the clinical trials.

ii.Patients belonging to either sex between the age group 30 years to 60years.

iii.Patients who are already diagnosed as Essential hypertension (EHT) will be selected.

iv.Patients having systolic blood pressure (SBP) up to 160 and diastolic blood pressure (DBP) up to 100 will be selected for the study and in any type of emergency condition patient will be treated in emergency.

Exclusion Criteria

i.Patient below the age of 30 years and above 60 years.

ii.Patient having systemic / serious complication of Cardiovascular / Cerebrovascular / Renal system.

iii.Hypertensive retinopathy

iv.Malignancy

v.History of liver diseases in the recent past (If the duration of the diseases is more than 5 years.)

vi.Pregnancy induced hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath